Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.20
$0.00 (0.00%)
At close: Oct 30, 2026, 3:59 PM ET
$10.19
-$0.01 (-0.10%)
After-hours:
Oct 30, 2026, 4:02 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 174.97K | 347.72K | 223 | 315.09K | 4.39K | 6.99K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 513.88M | 509.37M | 504.93M | 500.11M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | 101.83K | 93.52K |
Receivables | n/a | n/a | n/a | 566.27K | 2.6K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 217.82K | 351.76K | 26.04K | 896.36K | 11.57K | 11.57K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 513.88M | 509.37M | 504.93M | 500.11M | 101.83K | 93.52K |
Total Assets | 514.1M | 509.73M | 504.96M | 501.01M | 113.4K | 105.1K |
Account Payables | 12.25K | 49.17K | 99.36K | 4.59K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 450K | 450K | n/a | n/a | 297.29K | 250.1K |
Other Current Liabilities | 182.32K | n/a | 201.51K | 553.75K | n/a | n/a |
Total Current Liabilities | 644.57K | 666.29K | 300.86K | 677.35K | 327.51K | 281.14K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 17.5M | 17.5M | 17.5M | 17.5M | n/a | n/a |
Total Liabilities | 18.14M | 18.17M | 17.8M | 18.18M | 327.51K | 281.14K |
Total Debt | 450K | 450K | n/a | n/a | 297.29K | 250.1K |
Book Value | 495.96M | 491.56M | 487.16M | 482.83M | -214.12K | -176.05K |
Book Value Per Share | 9.92 | 9.83 | 36.66 | 177.68 | -0.01 | 0 |
Common Stock | 513.88M | 509.38M | 504.94M | 500.11M | 1.44K | 1.44K |
Retained Earnings | -17.93M | -17.82M | -17.78M | -17.28M | -249.12K | -211.05K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 495.96M | 491.56M | 487.16M | 482.83M | -214.12K | -176.05K |
Total Investments | 513.88M | 509.37M | 504.93M | 500.11M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMII